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Theconcept that IL-1 is produced and is an essential cofactor forT cell prolifera-
tive responses to antigens has not been extensively explored with fresh populations
of mononuclear cells . Recent studies in the mouse, with an IL-lot cDNA probe and
rIL-1 have indicated that IL-1 is produced during monocyte but not dendritic cell-
mediated, T cell proliferation (1) . Furthermore, the activating properties of exoge-
nous rIL-1 may be exerted at the level ofthe dendritic cell rather than theT cell (2) .
We have studied IL-1 production during the humanAPCT cell interaction . The
human system is advantageous since one hasaccess to monocytes and dendritic cells
in blood, as well as a useful group ofanti-IL-1 antibodies and antigen-specific clones .
We find that IL-1 can be produced, but may not be essential for secondaryT cell
responses to antigen-bearing monocytes, and that there are MHC-restricted and
nonrestricted pathways whereby T cells can induce IL-1 production by monocytes .
Volume 169 March 1989 1121-1136
Materials and Methods
CultureMedium.
￿
Complete medium was RPMI 1640 (Gibco Laboratories, Grand Island,
NY) supplemented with 5 x 10-5M2-ME, 20 hg/ml gentamycin (Gibco Laboratories), and
5-10% FCS (HyClone Laboratories, Logan, UT) or human AB` serum. FCS was used for
OKT3 (anti-CD3)-induced T cell proliferative responses while AB` serum was used in all
other circumstances .
Enrichment ofBloodMononuclear Cells, Monocytes, Dendritic Cells, and T Cells .
￿
Whole blood
or human leukocyte fractions (New York Blood Center, New York, NY) were layered onto
Ficoll Hypaque(Histopaque ; SigmaChemical Co., St. Louis, MO) and sedimented at 1,000
gfor 20 min at 21°C . The mononuclear cells were washed twice in RPMI and studied im-
mediately, or after 1-2 d in culture. Monocytes were enriched by adherence for 90 min at
37°C to plastic . Theadherent cells were55-85% monocytes by cytology and immunolabeling
with the anti-CD14mAb 3C10 (3) . This antibody stains a majority (>95%) of blood mono-
cytes anddoes not stainTcells, Bcells, or dendritic cells (3). When highly enriched dendritic
cells were required these were separated by a Percoll sedimentation method described else-
where (4) . The dendritic cells were obtained from the high density fraction by a multistep
procedure involving depletionofT cellsby sheep erythrocyte (E) rosetting, B cells by aden-
sity gradient, and residual monocytes by panningon dishes coated withhumangammaglobulin .
To isolate enriched populations of B cells and dendritic cells together from PBMC, T cells
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and monocytes were removed by E rosetting and gamma globulin panning, respectively (E- ,
FcR- population). T cells were sheep E rosette' cells depleted of monocytes and Ia' cells
by first panning on gamma globulin-coated dishes followed by panning on goat-anti-mouse
dishes afterincubation with an anti-Ia antibody. These T cells did not proliferate in response
to Con A or anti-CD3 (OKT3) antibody. CD4' T cells were purified by coating E rosette'
cells with a mixture of OKT8 (anti-CD8)and 9.3C9 (anti-class II) mAb followed by panning
on 100-mm petri dishes (No. 1005, Falcon Labware, Oxnard, CA) previously coated with
120 jug of goat-anti-mouse Ig (Cappel Laboratories, Malvern, PA) in 10 ml PBS without
calcium or magnesium (PD)'. The dishes were centrifuged twice at 35 g for 5 min at 40C .
Nonadherent cells were >95To CD4' lymphocytes and had <1% 3C10', Leu-16', Leu-2', or
9.3C9' cells.
The purity of T cells and accessory cells was monitored by staining with mAb analysis
on a FACscan instrument (Becton Dickinson & Co., Mountain View, CA). Adherent cells
were largely monocytes (>70%) by staining with 3C10 anti-CD14 mAb (indirect im-
munofluorescence with biotinylated horse anti-mouse Ig and FITC-avidin; Vector Labora-
tories, Inc., Burlingame, CA). The CD4' population was >95°Jo pure as determined by
staining with a combination of FITC-Leu-2 and phycoerythrin-Leu-3, (Becton Dickinson
& Co.). The CD4' cells had no detectable MHC class II' cells or monocytes (CD14'). Den-
dritic cells composed 3-5% of cells in the E-, FcR-, population and 25-50% of the Percoll-
enriched fractions. Dendritic cells stained brightly with mAbs to classII MHC products (9.309,
anti-HLA-DR; reference 4) but not with mAb to monocytes (3C10), NK cells (CD 16: 3G8,
Leu-11b), B cells (CD19: Leu-16) or T cells (CD 3, 4, 8: Leu-2, 3, 4).
TCell Clones.
￿
IL-2-dependent human T helper clones were grown as previously described
(5, 6). The allospecific T helper clones were A-57 (DR-2 reactive) and 86 (DR-1 reactive).
Both clones are CD3', CD4', and CD8- and have been shown to provide MHC-restricted
helper activity for allogeneic B cells as measured by the induction of B cell proliferation and
Ig secretion (5, 6). Before use, the T cell clones were washed out of FCS three times and
then recultured in RPMI 1640 (Gibco Laboratories) containing 5% human AB' serum.
These clones did not contain IL-1 as measured by immunofluorescence (see below).
Isolation ofDendritic-T Cell Clusters.
￿
To generate clusters of interacting T cells and den-
dritic cells, 1.5 x 106 T cells or CD4' cells were cultured with 0.3 x 106 partially enriched
dendritic cells (E-, FcR- fraction) in 1.5 ml of complete medium in 15-ml round-bottomed
plastic tubes (No. 2051; Falcon Labware). After 1-2 d of culture in the MLR or in the pres-
ence of3 p,g/ml Con A, the suspensions were gently collected and applied to Percoll gradients
generated from a solution of three parts FCS, four parts isoperc, and 5.5 parts HBSS (7).
Approximately 5-10 x 106 cells were applied to 12 .5 ml gradients and centrifuged for 5 min
at 4'C at 300 rpm. The clustered cells were found in the bottom portion of the gradient,
and the nonclusters were found in the top 2 cm. The clusters were washed free of Percoll
and then recultured or immediately cytospun onto glass slides for analysis of intracellular
IL-1 (Shandon cytospin 2; Shandon Southern Instruments, Sewickley, PA). In some experi-
ments, 30% serum gradients were used instead of Percoll gradients. Briefly, the mixture of
cells was layered onto 5 ml of RPMI containing 30% AB' serum. The clusters pelleted after
15 min at 4°C.
Isolation ofAntigen-speck Blasts.
￿
When dendritic-T cell clusters prepared as described above
were cultured, antigen-specific T blasts developed and were released after 48-60 h (7). The
blasts could be separated from residual clusters by reapplying the cell mixture to Percoll or
serum gradients. The isolated blasts responded to 1-10 U/ml of rIL-2 but reverted to IL-2-
unresponsive smaller cells if cultured without stimuli for 1-2 d (7).
Stimulifor IL-1 Production.
￿
Stimuli were usually applied for 24 h after.which the culture
fluid and cells were evaluated for IL-1 content (see below). The stimuli were: LPS, 20 ng
to 20 Wg/ml (Boivin preparation ofsalmonella typhosa; Difco Laboratories, Detroit, MI); PMA,
20 ng/ml (Sigma Chemical Co.); human rIFN-ti, 1.8 x 108 U/mg sp. act., 100 U/ml (gift
of Hoffman-LaRoche, Nutley, NJ); Con A, 3 pg/ml (Pharmacia Fine Chemicals, Uppsala,
' Abbreviations used in thispaper: GM-CSF, granulocyte/macrophage colony-stimulating factor; PD, PBS
without magnesium or calcium.BHARDWAJ ET AL.
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Sweden); anti-CD3, OKT3, 25 ng/ml (Orthodiagnostic Systems, Raritan, NJ); Leu-4, 25
ng/ml (Becton Dickinson & Co., Mountain View, CA); rIL-4, 100 U/ml (DNAX, Palo Alto,
CA); rGM-CSF; 5% cos7 supernatant and rIL-3 ; 5% cos7 supernatant (DNAX, kindly
provided by Dr. T. Yokota); rTNF 25 ng/ml (kindly provided by Dr. Helen Vlassara, Rocke-
feller University, New York), rIL-6, 500 U/ml (DNAX). To evaluate the capacity of T cells
to induce monocyte or dendritic cell IL-1, 5 x 10' enriched dendritic cells or 5 x 104 mono-
cytes were mixed with 1 .5 x 106 syngeneic or allogeneic blood T cells for 18-24 h. Syngeneic
cultures were stimulated with Con A (3 ug/ml) or OKT3 (25 ng/ml). To evaluate the capacity
of alloreactive T cell blasts or clones to turn on IL-1 in APC, they were cultured together
at various ratios (see Results) for different time intervals, and the cells were analyzed as de-
scribed below.
Identification ofIL-1-producing Cells by Immunolabeling.
￿
Preimmune and immune rabbit sera
generously provided by Drs. J. Schmidt and E. K. Bayne (8, 9) (Merck Institute of Research,
Rahway, NJ) were used to stain cells as described (10). Briefly, cell suspensions were cytospun
onto glass slides, fixed in paraformaldehyde, permeabilized in acetone, and stained with 1 :200
dilution of rabbit serum followed by FITC-goat (Fab')2 anti-rabbit IgG (Tago, Inc., Burlin-
game, CA). 100-200 cells from four different fields were counted to obtain the percentage
of IL-1-producing cells. To identify monocytes, the cells were double-labeled with biotin-mAb
(3C10 or anti-CD14), washed, and overlaid with phycoerythrin avidin (Becton Dickinson &
Co.) or streptavidinTexas Red (Amersham Corp., Arlington Heights, IL). This permitted
quantitation of the percentage of monocytes synthesizing IL-1 (see Results).
DIO.G4.1(`DIO) BioassayforIL-1.
￿
The D10 line is a murine helper T clone kindly provided
by Dr. C. A. Janeway (Yale University, New Haven, CT). The maintenance of the clone,
as well as its direct proliferative response to IL-1, have been described (10, 11). Briefly, super-
natants to be tested for IL-1 activity were added in graded doses of 50 to 0.15% vol/vol to
0.5-2 x 10' D10 cells in 0.1-ml medium in flat-microtest wells. [;H]Thymidine was added
at 4 /Ci/ml from 60 to 72 h . The D10 line did not respond to the various stimuli that were
used to induce IL-1 production from blood leukocytes including IL-4 and IL-6, while IL-2
was only minimally stimulatory (1,000-fold less sensitive than IL-1). The positive controls
were : an IL-1-rich supernatant from LPS-activated peripheral blood monocytes; human rIL-
la, specific activities 5 x 106 U/mg (kindly supplied by Dr. P. Lomedico, Hoffman-
LaRoche), human rIL-1/3, specific activity 2 .3 x 10' U/mg (kindly supplied by Dr. J . S.
Schmidt, Merck Institute of Research). Standard curves relating volume of supernatant to
the D10 response were used to determine IL-1 activity in U/ml where 1 U was defined as
that giving half-maximal activity in the D10 assay. The D10 cell line responded half-maximally
to the recombinant mouse and human IL-1 at a dose of 0.001-0.005 U/ml as defined by the
thymocyte mitogenesis assay. Where activity was too low to be accurately determined from
the standard curve, results are expressed as less than the lowest value measurable ofthe standard.
Thymocyte Proliferation Assayfor IL-1.
￿
In some experiments, culture supernatants were tested
with this assay. Briefly, 2 x 105 thymocytes from C3H/Hej mice were cultured with 1.5 jig/ml
of Con A and various dilutions of supernatant. Cultures were pulsed with 4 gCi/ml of
['H]thymidine from 48 to 60 h. Results are expressed in cpm as averages of triplicates.
Assayfor Detection ofIL-1-inducing Factors.
￿
To determine if T cells after contact with acces-
sory cells release IL-1-inducing factors, mixtures of T cells and APC were cocultured in upper
or lower chambers of double-chambered dishes (0.4 ,m, 6.5 mm Transwells; Costar, Cam-
bridge, MA) with unstimulated accessory cells (monocytes) in the alternate chamber. Both
populations were then analyzed for intracellular IL-1 production by immunofluorescence and
for IL-1 secretion in medium by the D10 assay.
Capacity ofAnti-IL-1 Antibody to Block T Cell Proliferation Assays.
￿
Responses to alloantigens
were induced by adding graded doses of viable, irradiated (3,000 rad "'Cs) accessory cells
to 1.5 x 105 allogeneic T cells (MLR) or 2-4 x 104 allogeneic T blasts or cloned T cells in
6-mm flat wells (No. 3596, Costar) in medium with 5% AB' serum . In some experiments
the accessory cells were not irradiated. For polyclonal mitogenesis, Con A (3' hg/ml) or OKT3
(25 ng/ml) was added to either 1.5 x 105 unseparated mononuclear cells or 1.5 x 105 T cells
cultured with 3 x 104 enriched accessory cells. Proliferation was measured by the addition
of 4 ACi/ml [3H]thymidine from 48-60 h for Con A- and OKT3-stimulated responses, and1124 INTERLEUKIN I AND ANTIGEN-PRESENTING CELLT INTERACTION
for growth of alloblasts and allogeneic clones. For primary MLRs, [3H]thymidine was added
from 120 to 136 h . Results are expressed incpm as averages of triplicates . To test ifneutraliza-
tion occurred, rabbit polyclonal anti-IL-1 antibody (generously provided by Dr. R . Newton,
du Pont de Nemours and Co., Glenolden, PA) was added to cultures at a final concentration
of 50,ug/ml . At this dose, the antibody blocks -20 U/ml of rIL-la and rIL-10 in the thymo-
cyte assay and comparable equivalent doses in the DIO assay. The antibody is an IgG fraction
ofimmune sera that was prepared by immunizinga rabbit with human monocyte-derived
IL-laand IL-1(3 (12) . The antibody does not significantly neutralize IL-2 or IL-6 bioactivity .
To verify neutralization in cultures ofAPC and T cells, supernatants were assayed for IL-1
activity in the D10 bioassay as described below.
Results
Using a single cell immunolabeling technique to identify intracellular IL-1(3 we
previously found that in blood and rheumatoid synovial effusions, the monocyte
was the principal if not the only leukocyte synthesizing this cytokine in response
to LPS(10) . We proceeded to use this approach, together with thecomparably sensi-
tive D10 bioassay to look for IL-1 production during the interaction of monocytes
and dendritic cells with T cells . In all cases we double labeled the leukocytes first
with biotinylated anti-CD4 (antimonocyte) mAb followed by streptavidin Texas Red
or phycoerythrin-avidin and then with anti-IL-1/3 plus FITC-goat anti-rabbit IgG
so that we could discern monocytes from T cells in the culture .
IL-1 Production during Primary T Cell Proliferative Responses .
￿
When populations of
blood mononuclear cells were stimulated with ConA or with OKT3 mAb for 18 h,
IL-1 was evident in up to 25-33% of the monocytes (Table I) . Lymphocytes were
not labeled. If the blood cells were stimulated after separation into populations en-
riched in monocytes, T cells, and mixtures of dendritic cells and B lymphocytes,
there was no IL-1 response to the mitogens although the monocytes responded to
LPS (Table I) . No IL-l' cells were seen in the mixtures of dendritic cells and B
lymphocytes in response to LPS and Con A, but some IL-1 activity was detected
in the medium (last two rows, Table I) . In several other experiments, no IL-1 ac-
tivity was detected in the medium of B cell-dendritic cell cultures stimulated with
these agents . Other stimuli, PMA and IFN- .y , did not induce the human monocyte
to synthesize IL-1 (Table I) .
Allogeneic monocytes or dendritic cells were cultured withT cells in the MLR,
but none of the cells were observed to contain IL-1 at 24 to 48 h . This was true
even in clusters of interacting dendritic cells and lymphocytes (Fig . 1), which are
the site in which theMLR is generated (7). At this stageT cell activation is already
initiated since IL-2 is readily detected within the culture supernatants (7). There-
fore it seems that IL-1 is not an early product in a primary, antigen-dependent re-
sponse like the MLR.
Alloreactive T Cell Clones Induce IL-1 in HLA-DR-specific Monocytes, but not Dendritic
Cells andB Lymphocytes . A different result was obtained when we examined the in-
teraction of monocytes with previously stimulatedT cells . A panel ofhumanCD4+
alloreactiveT cell clones, restricted to specific HLA-DR molecules, was cocultured
with different types ofAPC. DR1 + monocytes made IL-1 in response to theDR-1
specific clone 86, and DR-2` monocytes made IL-1 in response to the DR-2-specific
clone A57 (Table II). IL-1 was also present in theculture medium by bioassay (Table
II) . In most but not all cases the percentage of IL-1+ monocytes correlated with theBHARDWAJ ET AL .
TABLE I
Monocytes Synthesize IL-1 in Response to LPSandMitogen-stimulated T Cells
Bulk mononuclear cells or fractions enriched in monocytes, T cells, or B plus
dendritic cells, were stimulated for 18 h with the indicated stimuli . Thepercen-
tage of monocytes synthesizing IL-1 wasdetermined by the immunofluorescence
assay, and the IL-1 released, by the D10 assay . NT, not tested .
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FIGURE 1 .
￿
Aggregates of dendritic cells and allogeneic T lymphocytes, which are the site for
T cell proliferation in the MLR, were isolated after36 h of coculture by velocity sedimentation
and were stained for IL-1 .The clusters contain large dendritic cells (A, arrows) and smallerround
lymphocytes . No staining is observed with anti-IL-10 antiserum (B)above the preimmune back-
ground. x250 .
Population Mitogen
IL-1'
Monocytes IL-1
% U/ml
Mononuclear cells None <0 .1 <0 .05
LPS 88 f 14 16
ConA 26 f 4 <0.05
Leu-4 34 t 11 <0.05
OKT3 <0 .1 10
IFN-y <0 .1 <0.05
Monocyte-enriched None <0 .1 <0.05
LPS 91 f 6 67
ConA <0 .1 <0.05
Leu-4 <0 .1 <0.05
OKT3 <0 .1 <0.05
PMA NT <0.05
IFN-y NT <0.05
T cell-enriched None <0 .1 <0.05
LPS <0 .1 <0.05
Con A <0 .1 <0.05
OKT3 <0 .1 <0.05
IFN-y <0 .1 <0.05
B and dendritic None <0 .1 <0.05
cell-enriched LPS <0 .1 _5
Con A <0 .1 141126
￿
INTERLEUKIN 1 AND ANTIGEN-PRESENTING CELL-T INTERACTION
TABLE II
Alloreactive T Cell Clones Induce IL-1 in HLA-DR-specific c Monocytes
Approximately 5 x 105 monocytes from donors bearing distinct HLA-DR specificities were
cultured alone, with LPS, or with the indicated numbers oftwo alloreactive T cell clones. Clone
86 is specific for DR-1, and clone A57 for DR-2. The percentage of monocytes synthesizing
IL-1 was determined at 24 h using the immunolabeling assay, and the IL-1 bioactivity in the
culture medium using the D10 proliferation assay. The monocyte-enriched populations were
70-83% CD14' in the different experiments.
secreted IL-1 activity. The IL-1 + cells were monocytes and not T cells since they
were double labeled with anti-CD14. The frequency of IL-1+ monocytes was
proportional to the T cell dose, with optimal responses involving 15-30% of mono-
cytes at a 1 :1 monocyte/T cell ratio(Table II). No further increase in the proportion
of IL-1' monocytes was noted with a fourfold excess of T cells (not shown).
The time course ofIL-1 productionwasexamined over a 24-h period. At optimal
clone-to-monocyte ratios, IL-1 was detected asearly as 6 h and peaked at 24h (Table
III), which is similar to the kinetics observed with LPS (10). The number of IL-1 +
monocytes declined after 24 h (not shown).
Mixturesofdendriticcells andB cellswere prepared by depletingbloodmononuclear
cells ofTcells and monocytes by rosetting with sheep erythrocytes and panning on
IgG-coated plates, respectively. <1% of these APC stained with anti-CD14 mono-
cyte mAb. 3-5% were dendritic cells in cell size and shape and by strong staining
with anti-MHC class II but lack ofstaining with Leu-12 and Leu-16 anti-B cell re-
agents. The mixtures of B cells and dendritic cells induced strong proliferation of
the T cell clone, but neithertype ofAPC nor theTcells made IL-1 even when LPS
was added (Table IV). These findings indicate that monocytes are the main source
of IL-1 during HLA-DRrestricted interactions with T cell clones and suggest that
IL-1 is not essential for antigen specific proliferation by the T cell clone.
Alloreactiae T Cell Blasts Induce IL-I in MHC-specific Monocytes, but not other Leuko-
cytes. To assess ifthe findings with T cell clones were applicable to freshly sensi-
tized, alloreactive T cells, the latter were isolated from a primary MLR and
rechallenged with HLA-DR-specificand nonspecific APC. Coculture ofthe T blasts
HLA-DR
of APC Stimulus
Number of
cloned T cells
IL-1'
monocytes IL-1 released
U/mi
DR-1 None <0.1 0.1
LPS 65 +_ 0 .5 54.0
Clone A57 5 x 105 <0.1 0.1
Clone 86 5 x 105 16 + 6 7.7
3 x 105 16 +_ 4 5.2
1 x 105 1 + 1 2.5
5 x 104 0.5 + 1 0.2
DR-2 None <0.1 0.04
LPS 71 +_ 2 97.00
Clone 86 5 x 105 <0.1 <0.01
Clone A57 5 x 105 13 + 10 <0.01
3 x 105 13 + 2 10.00
1 x 105 4 + 0.5 <0.01
5x 104 3+ 1 <0.01BHARDWAJ ET AL.
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TABLE III
Kinetics of T Cell-mediated IL-1 Induction in Monocytes
Monocyte-enriched populations, from HLA-DRI (Exp. A) or HLA-DR2 (Exp.
B) individuals, were cultured with LPS or with clones 86 and A57 for the indi-
cated times. The percentage of CD14' cells synthesizing IL-1 (standard devia-
tions) was determined by the immunolabeling assay.
with monocytes at a 1:1 ratio for 12 h was sufficient to induce IL-1 in 10-25% of
class II-specific but not nonspecific or syngeneic monocytes (Table V). In one in-
stance, alloreactive T blasts (anti-DR-2,7) did not induce significant IL-1 synthesis
in MHC-specific monocytes (DR-2,7). This may be due to the fact that alloblasts
are a more heterogeneous population thancloned T celllines. Alternatively, thedose-
response requirements mayhave beendifferentforthisparticular preparation ofTcells.
The T cells had to be activated to induce IL-1 since no induction ofcytokine was
observed in mixturesofmonocytes and fresh, allogeneic T cells (see above). As with
the studies ofTcell clones (see above), dendritic cells and B cells did not make IL-1
in cultures set up in parallel with the monocyteTblast mixtures (data not shown).
MechanismofIL-1Induction inMonocytes by TCells.
￿
The mechanism wherebyacti-
TABLE IV
Monocytes, but not Dendritic Cells and B Cells Make IL-1
in Response to T Cell Clones
IL-1 induction in different APC (percent IL-I')
DR-1' DR-4' DR-i+ DR-4'
Stimulus
￿
Monocytes
￿
Monocytes
￿
B + DC
￿
B + DC
None
￿
<0.1 <0.1 <0.1 <0 .1
LPS
￿
76 t 9
￿
91 t 12
￿
<0.1
￿
<0.1
Clone 86, a-DR-1
￿
13 t 0 .2
￿
<0.1
￿
<0.1
￿
<0 .1
DNA synthesis per culture (cpm [3H]TdR)
None
￿
217 217 407 223
Clone 86, a-DR-1
￿
8,525
￿
213
￿
13,909
￿
165
Monocytes and enriched populations of B cells and dendritic cells (B + DC)
were cultured with the indicated stimuli. The percentage of APC synthesizing
IL-1 at 20 h was calculated using the immunolabeling assay. DNA synthesis was
measured by adding [3H]TdR from 48 to 60 h. The cpm for the T cell clone
cultured in the absence of APC was 158 cpm .
Exp.
Culture
time
HLA-DR
of monocytes
IL-1'
None
monocytes
LPS
after stimulation with:
Clone 86 Clone A57
(a-DR-1) (a-DR-2)
h %
A 0 DR-1 <0.1 1 .6 (.2) <0.1 <0.1
24 DR-1 <0.1 52 (2) 53 (1) <0.1
B 0 DR-2 <0.1 1 .3 (2) <0.1 0.6 (1)
2 DR-2 <0.1 <0.1 <0.1 <0.1
6 DR-2 <0.1 39 (1) <0.1 9.0(3)
24 DR-2 <0.1 73 (5) <0.1 8.0 (2)1128
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TABLE V
Alloreactioe T Cell Blasts Induce IL-1 in HLA-speck Monocyles
Equal numbers ofCD4' T cell blasts were cultured with monocytes from differ-
ent donors. a-DR-1,5 blasts were raised by culturing accessory cells from JM
with T cells fromJS (DR-2,7), and a-DR-2,7 blasts were developed from cocul-
tures ofJM T cells and JS accessory cells. JM and JS are disparate at all loci
in the HLA complex, while donor PSF (DR7) appears to share determinants
with both JS and JM, since blasts generated against either JS orJM proliferat-
ed to PSF. Supernatants from the cultures ofblasts and APC were tested in the
D10 assay, and the IL-1 released was determined by regression analysis against
a standard of rIL-1/3. The percentage of monocytes synthesizing IL-1 was de-
termined by immunolabeling with an a-IL-10 antibody and double labeling with
a-CD14, 3C10 mAb . The percentage ofCD14' cells in each fraction was: JM,
87 ; JS, 73; PSF, 78.
vatedT cells induce IL-1 in monocytes was analyzed. Two possibilities were consid-
ered: thecloneorlymphoblastcould triggerthe monocytebydirect cell-cellinterac-
tion, or the APC or T cell could release an IL-1-inducing cytokine, as suggested
by data from studies with murine T cell clones (13, 14). Monocytes were cultured
in media that had been conditioned in three different APCTcell cocultures: clone
86 and DR-I' monocytes; alloblasts with MHC-specific monocytes; or the primary
MLRbetweendendriticcellsandT cells. Concentrations ofsupernatant inthe range
of25-50% did not induce IL-1 (not shown). There was no suppressive factor in the
supernatants since the addition of LPS induced IL-1 (not shown). Several specific
recombinant cytokines did not induce IL-1 inmonocytes including: IL-4 (100U/ml),
Exp.
Donor of
monocytes Stimulus IL-1
U/ml
IL-1'
monocytes
A DR-1,5 None <0.1 <0.1
LPS 297 74 t 18
a-DR1,5 T cell 49 18 f 7
a-DR-2,7 T cell <0.1 <0.1
DR-2,7 None <0.1 <0.1
LPS 281 92 +_ 12
a-DR-1,5 T cell <0.1 <0.1
a-DR-2,7 T cell <0.1 2 ± 0.3
DR-7 None 10 2 + 0 .2
LPS 329 59 f 7
a-DR-1,5 T cell 65 6 ± 0 .8
a-DR-2,7 T cell 29 11 ± 0 .7
B DR-2,7 None <0.1
LPS 73 + 10
a-DR-2,7 T cell 26 ± 4
a-DR-5 T cell <0.1
DR-5 None <0.1
LPS NT 93 t 9
a-DR-2,7 T cell <0.1
a-DR-5 T cell 15 +_ 5
DR-4,10 None <0.1
LPS 94 +_ 0 .4
a-DR-2,7 T cell <0.1
a-DR-5 T cell <0.1BHARDWAJ ET AL.
TNF/cachectin (25 ng/ml), IL-6(500 U/ml), IL-3 (5% cos7 supernatant), GM-CSF
(5% cos7 supernatant), and IFN-.y (100 U/ml).
To further exclude a role for IL-1-inducing cytokines, two chamber experiments
were performed. Alloreactive T cells and MHC-specific monocytes orenriched den-
dritic cellswere cultured inone wellwhich was separated from third-partyfreshmono-
cytesby a0.4-/Am filter. Inthree offourexperiments, no IL-1 wasdetected (notshown).
In a fourth experiment, a small percentage ofmonocytes (3%) synthesized IL-1 by
immunolabeling, compared with 12% synthesizedin thecoculturesofalloblasts and
MHC-specific monocytes. Thiswas notdue tocarryover ofendotoxin, since <5 pg/ml
ofendotoxinwas detectable inthe culture supernatants. Ofinterest was the finding
that a 30% dilution of supernatant from the alloblast and MHC-specific monocyte
cultures also induced 4% of fresh third-party monocytes to produce IL-1. Thus a
more potent pathway for IL-1 induction in monocytes seems to be through direct
MHC-speck contact rather than via release of inducing factors.
Induction ofIL-1 in HLA-DR NonspecificMonocytes in Cocultures of T Cell Clones and
HLA-DR-speck Dendritic Cells. A remarkable result was obtained when we cocul-
tured DR-1 dendritic cells, DR-1-specific clone 86, and DR3,4 nonspecific mono-
cytes. Thelatter were found to synthesize IL-1, andto a comparable extent to DR-1
monocytes cultured with clone 86 (Table VI, Fig. 2). DR3,4 monocytes, however,
would not synthesize IL-1 when cultured with clone 86 in the absenceofDR-1 den-
dritic cells (2nd and 4th groups in Table VI).
Identical results were obtained with alloreactive T blasts (not shown) . Coculture
ofalloreactiveblasts, MHC-specific dendritic cells, and nonspecific"bystander"mono-
TABLE VI
IL-1 Induction in HLA-DR-nonspecific Monocytes by an Alloreactive T Clone
APCfrom DR-1 or DR-3,4 donors were cultured in the absence ofstimuli, orwith LPS, clone
86, and/or monocytes from either donor. After 20 h the cells were analyzed for IL-1 produc-
tion by the immunolabeling assay.
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APC population Stimulus IL-1-bearing monocytes
DR-1 monocytes None <0.1
LPS 77 t 5
Clone 86, a-DR-1 34 t 18
DR-3,4 monocytes None <0 .1
LPS 78 t 13
Clone 86, a-DR-1 <0 .1
DR-1 B cell plus DC None <0 .l
LPS 1 t 0.6
Clone 86, a-DR-1 0.3 t 0.2
DR-3,4 monocytes <0.1
Clone 86 + DR-3,4 monocytes 18 t 0.5
DR-3,4 B cell plus DC None <0.1
LPS <0.1
Clone 86, a-DR-1 <0.1
DR-1 monocytes <0.1
Clone 86 + DR-1 monocytes 25 f 21130
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FIGURE 2 .
￿
DR-specific dendritic cells and alloreactiveT cell clone induce IL-1 in non-DR-specific
monocytes . Enriched dendritic cells, monocytes, andT cell clone were cultured for 24 h and
stained with biotinylated 3C10 (anti-CD14) and streptavidinTexas Red, followed by anti-IL-1
antisera and FITC-conjugated goat anti-rabbit IgG . (A-C)DR-I DC cultured with clone 86(DR
1-reactive) . (A'-C') DR-1 dendritic cells cultured with clone 86 andDR-5 monocytes . (A, A')FITC
stain, (B, B') streptavidin stain; (C, C') phase contrast of the same respective fields . IL-1 * mono-
cytes are indicatedby white arrows (A') and represent -20% of the total monocyte population .
x250 .
cytes led to IL-1 synthesis in the latter. TheMHC nonspecific monocytes could be
third-party or syngeneic to the T blasts . However, as noted above, if dendritic cells
and T blasts were placed in one chamber separated from monocytes by a 0.4-/.m
filter in another, little or no IL-1 induction occurred .
These results suggest that when T cells are being stimulated by dendritic cells,
some MHC-nonrestricted mechanism leads to induction ofIL-1 by monocytes, pre-
sumably by cell contact rather than an IL-1-inducing factor.BHARDWAJ ET AL.
TABLE VII
Anti-IL-1 Antibody Does Not Block the Proliferation of an Alloreactive T
Cell Clone to Monocytes, B Cells, or Dendritic Cells
Proliferation ofclone 86 alone was 989 cpm. The anti-IL-1 antibody and rabbit
IgG were added at 50 jug/ml. Parentheses denote amount o£ IL-1 released in
culture supernatant expressed as U/ml ofactivity in the thymocyte co-stimulation
assay. Two different DR-I' donors were used in the above experiment.
TABLE VIII
Anti-IL-1 Does Not Block the Proliferation of Alloreactive T Blasts to Antigen-bearing Monocytes,
B Cells, or Dendritic Cells
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CD4` T cells were induced to become blasts in an MLR to dendritic cells (DC) (see Materials and Methods).
The blasts were rechallenged with the indicated syngeneic or allogeneic APC and antibodies; [3H]TdR up-
take was measured at 72-90 h. The cell doses were Exp. A: 105 blasts and either 105 monocytes or 3 x 104
DC + B cells; Exp. B: 2 x 104 blasts and 1 .5 x 105 monocytes. In Exp. B we also cultured 5 x 105 blasts
for 12 h with 106 monocytes; only the HLA-specific monocytes made IL-1 (45% IL-1' monocytes) by the
immunolabeling assay (not shown). The supernatants were collected and assayed for IL-1 activity in the D10
assay. The units/milliliter IL-1 are shown in parentheses. The proliferation ofthe T blasts without APC ranged
from 0.5 to 2.2 x 103 cpm .
Added HLA-DR to which T Antibody Response to APC :
Exp. as APC blasts are primed added HLA-DR 1,5 HLA-DR 2,7
cpm x 10-3
A Monocytes DR-1,5 None 71 .0 8.7
Control Ig 60.3 13.0
a-IL-1 58 .5 10.0
DC + B cells DR-1,5 None 87 .5 7.4
Control Ig 73 .3 5.3
a-IL-1 69 .8 7.8
HLA-DR-1, DQwl HLA-DR 2,7
B Monocytes DR-2,7 None 2.8 (<0.01) 18.6 (58)
Control Ig 3.8 17 .0
a-IL-1 6.8 (<0.01) 28.3 (<0.01)
DR-1, DQwI None 48.8 (147) 3.7 (<0.01)
Control Ig 35.6 2.9
a-IL-1 49.3 (<0.01) 11 .0 (<0.01)
Allogenic
Stimulator
Proliferation ofT cell
No Clone 86,
clone no Ig
clone ([3H]TdR
Clone 86,
anti-IL-1
incorporation)
Clone 86,
control Ig
cpm
DR-1 monocytes 1,484 30,627 29,568 26,270
(42) (<0.0001) (41)
DR-1 monocytes 815 52,733 55,201 56,604
(83) (0.8) (83)
DR-7 monocytes 785 878 893 280
(5 .4) (<0.0001) (6.0)
DR-1 B cells + DC 1,349 65,689 63,082 36,533
(1 .8) (<0.0001) (6 .3)
DR-1 B cells + DC 1,806 30,565 23,619 29,397
(17) (10) (23)
DR-7 B cells + DC 3,224 3,431 901 1,670
(16) (6) (18)1132
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Significance ofIL-1 Production in the T Cell Proliferative Response.
￿
Additional experi-
ments were performed to assess the role of IL-1 in T cell proliferation, given the
evidence that this cytokine was produced when monocytes rather than dendriticcells
were the APC. First we added a polyclonal anti-IL-1 a/(3 antibody using nonim-
mune rabbit Igas control. To ensure that IL-1 was being produced and neutralized
in these cultures, supernatants fromthe same microtiter wells were assayed for IL-1
in the thymocyte comitogenesis assay. As shown in Table VII, IL-1 was produced
in cocultures of clone 86 (anti-DRI) and DRl monocytes but not DR7 monocytes.
This IL-1 wasneutralized byanti-IL-1 antibodybutnot control Ig. Somethymocyte
costimulatory activity was present in dendriticTcell cocultures, but this was prob-
ably due to IL-2 since it was not neutralized by anti-IL-1. When either monocytes
or dendritic cells were the APC, anti-IL-1 did not neutralize the proliferative re-
sponse of the T cell clone (Table VII).
Similar results were obtained with freshly sensitized T blasts, that is, anti-IL-1
did not block the proliferative response to allogeneic monocytes or dendriticTcell
mixtures(Table VIII). The IL=1 that waspresent in themonocyteTblastcocultures
was neutralized with anti-IL-1 inthe D10 assay. Furthermore, neutralizinganti-IL-1
did not block the primary MLR or polyclonal mitogenesis to Con A, OKT3, or
PHA when monocytes or dendritic cells were the accessory cells (data not shown).
Discussion
There is evidence that IL-1 is produced by APC during their interaction with
murine T cells (13, 14), and that IL-1 enhances T cell proliferative responses (2,
15, 16). However, the production and significance of IL-1 in cultures offreshly iso-
lated leukocytes, as opposed to long-term cell lines, has not been well characterized.
There is recent evidence that murine T cell clones make IL-1 (17), so thatthe contri-
bution ofT cells in fresh leukocyte populations needs to be considered. The single
cell immunolabeling approach ofBayne et al. (8)has allowed usto studyIL-1 produc-
tion in human cells and to make the following findings.
Antigen-dependent, MHC-restricted Induction ofIL-1.
￿
IL-1 was detected during the
MLR to HLA-DR specific stimulators, but there were two requirements for op-
timal production. One was that the T cell had to be preactivated, since alloreactive
T blasts and Tcell clones induced IL-1 but unprimed T cells did not. The second
was thatmonocytes made IL-1, but dendriticcells and B cells did not. Furthermore,
the induction in monocytes was MHC restricted. Dendritic cells did not make IL-1
even when clustered with T cells during the first 48 h ofan MLR (Fig. 1). At this
stage T cell activation is already initiated since IL-2 can be detected in culture su-
pernatants (7). In no instance did we detect IL-1 in the T cell. Monocytes also pro-
duced IL-1 in Tcell-dependent responses to lectin and to anti-CD3 mAb (Table
I), but it is not clear ifthe effective T cells were unprimed lymphocytes or if they
hadbeenprimed insitu. It is ofinterest that eventhough all monocyteswere heavily
rosettedwithT cells inthe presence oflectin or anti-CD3 (not shown), onlyaminority
made IL-1 (Table I).
Together these observations suggest that IL-1 production is primarily a product
oftheefferent rather thanafferent limb ofaTcell-mediated immune response. Com-
parable conclusions have been reached in the murine system, although a single cellBHARDWAJ ET AL.
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assay was not available. There, a cDNA probe for IL-la mRNA was used on popu-
lations of macrophages and alloreactive T blasts that were separated and probed
after their antigen-dependent interaction (1). Only the monocytes were induced to
express IL-1amRNA. In contrast to LPS, which induced the majorityofmonocytes
to synthesize IL-1, alloreactive T cells induced IL-1 in 10-30% of MHC-specific
monocytes. This differencecouldbe dueto the degree ofphysical interactionoccur-
ringbetween Tcells and monocytes in culture. However, even with a fourfold excess
ofT cells, no increase in the frequency of IL-1+ monocytes was detected. Alterna-
tively, only discrete subsets ofmonocytesor T cellsmay be involved inthe induction
of IL-1.
An MHC-unrestricted Pathwayfor IL-1 Production.
￿
The observation that dendritic
cellsdidnot makeIL-1 allowed usto lookforMHC unrestricted pathways formono-
cyte IL-1 production. The first observation was that IL-1-inducingfactors could not
be definitively identified in two-chamber protocols. When T cell clones or blasts
were undergoing intense proliferative responses to MHC-specific dendritic cells in
one chamber, and MHC nonspecific monocytes were placed in the other, the mono-
cytes did not make IL-1. However, if the three cell types were cultured together in
one vessel, monocyte IL-1 was induced. IL-1 was notdetected in control experiments
in which the dendritic cells were MHC nonspecific, or either dendritic cells or T
cells were omitted.
It is conceivable that IL-1-inducing factors are released but that these can only
act across short distances rather than across a filter. Alternatively, dendritic cells
and/or T cells release factors that alter the monocyte so that it physically interacts
and responds to T blasts in an antigen-independent or MHC-unrestricted fashion.
For example, Dustin et al. (18) have shown that IFN-y can upregulate ICAM-1 on
keratinocytes and that the latter then bind T blasts by an LFA-1-dependent mecha-
nism. This sort ofantigen-independent mechanismmightgreatlyamplify IL-1 produc-
tion during an antigen-initiated immune response.
Function ofIL-1 in T Cell Proliferation.
￿
The fact that dendritic cells stimulate T
cells but do not make IL-1 when cultured with LPS (10, Table I) or responding T
cells(Fig. 1, Tables IV andVI)suggests that IL-1 isnot essential forT cell activation
in man or in mice (1, 11). These experiments were extended using a neutralizing
anti-IL-1 antibody that did not block dendritic cell-mediated responses to alloan-
tigen or Con A (Tables VII and VIII). We were unable to block T cell proliferative
responses to antigen-bearing monocytes even though the latter were making IL-1,
and the IL-1 in the medium was neutralized (Tables VII and VIII). Therefore, un-
less the anti-IL-1 antibody does not gain access to zones of intercellular contact,
one must question the longstanding view that IL-1 is an important T cell stimulant,
which toourknowledgehas not been supported byexperiments inwhich theprolifer-
ation of primary T cell populations has been blocked by anti-IL-1.
In the mouse, IL-1 can be essential for (19), or might enhance (20), the growth
ofIL-4-dependent T celllines. It is ofinterest that one ofthe T cell clones we used,
clone 86, makes IL-4 but not IL-2 (21). Supernatants from clone:APC cocultures
fail to induce growth ofthe IL-2 dependent line CTLL but can enhance CD23 (Foe
receptor) expression on B cells (21), a property determined to be dependent upon
IL-4 (22). Clone 86 is as efficient as fresh, alloreactive T blasts in inducing IL-1,1134 INTERLEUKIN 1 AND ANTIGEN-PRESENTING CELL-T INTERACTION
but it still proliferates in the presence of neutralizing anti-IL-1. Further studies of
other IL-4-producing cells will help evaluate the generality of the role of IL-1 in
inducing growth of IL-4-producing T cell clones and primary populations.
Another role for IL-1 could be to induce IL-6, as from fibroblasts (23), and IL-6
would then act as a growth factor forTcells (24-26). We are studying the produc-
tion of IL-6 by human APC, but as yet we have not detected a role for IL-1 in in-
ducing IL-6 in either dendritic cells or monocytes, in contrast to diploid fibroblast
cell lines.
Yet another contribution ofIL-1 to T cell proliferation is to enhance the function
and production of dendritic cells, which can then act on the T cell in an IL-1-
independent fashion (2, 27). In our experience, IL-1-pulsed human dendritic cells
were two- to threefold more active accessory cells for both the MLR and lectin re-
sponses. By this pathway, exogenous IL-1 could indeed amplify T cell proliferation
without acting directly as a lymphocyte-activating factor.
Summary
We have studied the control and significance ofIL-1 production in humanleuko-
cyte cultures during accessory cell-dependent, Tlymphocyte mitogenesis using sen-
sitive bioassays and immunolabeling techniques. In primary antigen-dependent
systems like the MLR, IL-1 production was not detected in accessory cells (mono-
cytes, dendritic cells) or T cells, suggesting that it is not an early product in these
responses. However, monocytes could be induced tomake IL-1 afterinteractingwith
sensitized antigen-specificT cells. Both alloreactive T cell clones orfreshlyprepared
lymphoblasts induced IL-1 provided the monocytes carried the HLA-DR antigens
to which the T cellswere initially sensitized. Even in these circumstances, dendritic
cells and B cells failed to make IL-1.
Themechanism wherebyactivated Tcells induce IL-1 in monocyteswas explored.
Supernatants from cocultures of monocytes and T cells or several recombinant
cytokines induced little orno IL-1. A more potent antigen independent pathway of
IL-1 induction was identified. IL-1 could be induced in third-party HLA-DR
nonspecificmonocytes in cocultures ofalloreactive T cell clones orblasts and HLA-
DR-specific dendritic cells. The induction was factor independent since dendritic
cells and T blasts placed in a chamber separate from third-party monocytes by a
semipermeablemembrane did not induce monocyte IL-1. Theseresults suggest that
acell contactmechanism rather than an IL-1-inducing factor leads to IL-1 production.
The role ofIL-1 inTcell proliferation was tested with a polyclonal anti-IL-1 anti-
body. The antibody failed to block the proliferation ofprimary T cells, or alloreac-
tive Tcell clones and blasts stimulated with HLA-specific monocytes or dendritic
cells, even though IL-1 in the medium was neutralized.
Received for publication 28 September 1988.
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